Acute Porphyria Drug Database

Monograph

B01AB09 - Danaparoid
Not porphyrinogenic
NP

Rationale
Glycosaminoglycan. Non-CYP dependent metabolism.
Chemical description
Antitrombotic depolymerized heparin

Similar drugs
Explore alternative drugs in similar therapeutic classes B01A / B01AB or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
Netherlands
Danaparoid natrium · Danaparoid natrium Viatris, 750 anti-Xa eenheden/0,6 ml, oplossing voor injectie/infusie · Danaparoid natrium Viatris, 750 anti-Xa-eenheden, oplossing voor injectie · Orgaran · Orgaran, 750 anti-Xa eenheden, oplossing voor injectie
Belgium
Orgaran · Orgaran 750 anti-Xa U sol. inj. s.c./i.v. amp.
United Kingdom
Danaparoid · Danaparoid sodium 750units/0.6ml solution for injection ampoules · Orgaran · Orgaran 750units/0.6ml solution for injection ampoules
Denmark
Orgaran
Luxembourg
ORGARAN
Finland
Orgaran
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙